NEC
9.3.2020 04:02:12 CET | Business Wire | Press release
NEC Corporation (TOKYO: 6701) today announced a collaboration with Siemens in the IoT field to provide a monitoring and analysis solution for manufacturing that connects MindSphere®, the cloud-based, open Internet of Things (IoT) operating system from Siemens, and NEC's System Invariant Analysis Technology (SIAT). As part of the agreement, NEC is joining the MindSphere Partner Program, which can provide NEC with access to specialized technical training and support from Siemens as well as a number of joint go-to-market capabilities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200308005027/en/
In recent years, with the acceleration of digitization and the spread of IoT, the safety, efficiency, maintenance and product quality of systems are being visualized and analyzed based on data collected from a large number of sensors installed in various locations, such as plant systems, manufacturing lines and factories. However, it is necessary to systemize data collection, storage, monitoring, analysis and other processes in order to utilize sensor data. Moreover, unique know-how, such as knowledge about IoT systems and data analysis, is required to construct such a system, making it difficult for customers to construct by themselves.
In addition, especially in the manufacturing industry, work processes are often based on the expertise of each plant or individual. Therefore, the loss of know-how due to the retirement of skilled personnel and lack of staff poses a serious challenge.
In order to solve these issues, NEC and Siemens have enhanced their products to enable greater visualization and analysis of sensor data.
System Invariant Analysis Technology, part of NEC's cutting-edge portfolio of AI technologies, "NEC the WISE", is being used to automatically learn and model the behavior of systems based on data gathered from a large number of sensors installed in large-scale, complex systems. This provides visualization of systems and how they operate, in addition to enabling systems to operate safely and efficiently by proactively detecting errors using analytical models. NEC has already installed approximately 100 such systems internationally.
MindSphere is the cloud-based, open IoT operating system from Siemens that connects products, plants, systems, and machines, enabling companies to harness the wealth of data generated by the IoT with advanced analytics. The MindSphere Partner Program is Siemens’ partner program for industrial IoT solution and technology providers.
This collaboration enables both companies to provide total data collection, storage, monitoring and analysis, including customization according to customer needs. Specifically, MindSphere is being used to collect and accumulate field sensor data and NEC's System Invariant Analysis Technology system automatically monitors and analyzes the data. This solution will first be offered as a cloud solution for the manufacturing industry, then applied to factory systems, manufacturing lines, plant facilities and other equipment, as well as products that are produced using this equipment. This makes it easy to visualize and analyze vast amounts of sensor data, thereby contributing to increased productivity, reduced operational risk, product quality and the preservation of know-how.
The companies plan to target customers in manufacturing industries internationally, then expand to customers in other industries.
"It is an honor to collaborate with Siemens to enhance the productivity of the manufacturing industry through System Invariant Analysis Technology,” said Osamu Fujikawa, Senior Vice President, NEC Corporation. “NEC will accelerate the digitization of enterprises through the provision of solutions worldwide that leverage both companies’ strengths. NEC will continue to address diversifying needs by fusing real and digital technologies as well as by leveraging advanced technologies such as AI and IoT,” he added.
"Siemens is committed to creating partnerships that help customers realize digital transformation with Industrial IoT. Working with NEC can help provide MindSphere applications that improve customers’ ability to add value to their digital transformation initiatives,” said Kunihiko Horita, Japan Country Manager, Siemens Digital Industries Software.
About NEC Corporation:
For more information, visit NEC at www.nec.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200308005027/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
